Home > List of Issue > Table of Contents > Abstract

Journal of Nippon Medical School

Full Text of this Article

-Case Reports-

Meralgia Paresthetica Caused by Surgery in the Park-Bench Position

Rinko Kokubo1, Kyongsong Kim1, Katsuya Umeoka1, Toyohiko Isu2 and Akio Morita3

1Department of Neurosurgery, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan
2Department of Neurosurgery, Kushiro Rosai Hospital, Hokkaido, Japan
3Department of Neurosurgery, Nippon Medical School, Tokyo, Japan


Objective: Meralgia paresthetica (MP) is an entrapment neuropathy of the lateral femoral cutaneous nerve (LFCN). We report a rare case of MP after microvascular decompression (MVD) surgery in the park-bench position in a patient with hemifacial spasm.
Case: The patient was a nondiabetic 46-year-old woman (height: 155 cm, weight: 42 kg) who consumed alcohol infrequently. After a first MVD for right hemifacial spasm, the symptom recurred and she underwent a second MVD procedure in the park-bench position, after which hemifacial spasm resolved. However, she reported right anterolateral thigh pain and dysesthesia without motor weakness. The pain was limited to the LFCN area, and a pelvic compression test elicited a positive Tinel-like sign. Our preliminary diagnosis was MP. Because conservative therapy was ineffective, she underwent LFCN block 9 months after the second MVD procedure. Her pain improved dramatically and we made a definitive diagnosis of MP. There has been no recurrence after 30 months of observation, although she reported persistent mild dysesthesia in the LFCN area.
Conclusion: MP is a rare complication after MVD surgery in the park-bench position. LFCN block can resolve symptoms and hasten diagnosis.

J Nippon Med Sch 2022; 89: 355-357

Keywords
lateral femoral cutaneous nerve, park-bench position

Correspondence to
Rinko Kokubo, MD, PhD, Department of Neurosurgery, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan
rin-ko927@nms.ac.jp

Received, December 19, 2020
Accepted, February 3, 2021